NeuroSense Therapeutics Ltd. - NRSN
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q4 2025
· Q3 2025
Value (USD)
Total reported value ($000)
$259K
QoQ value delta ($000)
-$85K
(-24.71%)
Implied price effect (QoQ)
-39.55%
Shares
Total shares
346,134
QoQ shares delta
+68,209
(+24.54%)
Total shares held by funds (by quarter)
Market chart (NRSN)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q4 2025)
Top 25 only
Full list
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Yorkville Advisors Global, LP | 76 | 100,000 | 0.05% |
| TWO SIGMA INVESTMENTS, LP | 39 | 51,545 | 0.0% |
| MEITAV INVESTMENT HOUSE LTD | 30 | 40,000 | 0.0% |
| GTS SECURITIES LLC | 27 | 35,753 | 0.0% |
| UBS Group AG | 23 | 30,871 | 0.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | 17 | 22,775 | 0.0% |
| Squarepoint Ops LLC | 13 | 17,926 | 0.0% |
| Pathstone Holdings, LLC | 12 | 16,528 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 12 | 15,870 | 0.0% |
| Creative Planning | 9 | 11,911 | 0.0% |
| SBI Securities Co., Ltd. | 1 | 1,455 | 0.0% |
| JONES FINANCIAL COMPANIES LLLP | 0 | 1,000 | 0.0% |
| Jessup Wealth Management, Inc | 0 | 500 | 0.0% |